| RS1131691587 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691588 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691590 |
GRIN1
|
Health Risk |
Pathogenic |
— |
| RS1131691592 |
WDR45
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS1131691593 |
DNAJC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome, Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome |
| RS1131691594 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS1131691595 |
NTRK1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691596 |
RANBP2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691597 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1131691598 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1131691599 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1131691600 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1131691601 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1131691602 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1131691603 |
PCDH19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1131691604 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691605 |
PROS1
|
Health Risk |
Pathogenic |
— |
| RS1131691606 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1131691607 |
COL1A1
|
Health Risk |
Pathogenic |
— |
| RS1131691608 |
DDX3X
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691609 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS1131691610 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1131691611 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1131691612 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1131691614 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1131691615 |
SLC19A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1131691616 |
ZC4H2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Wieacker-Wolff syndrome |
| RS1131691617 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS1131691618 |
TP53
|
Health Risk |
Pathogenic |
— |
| RS1131691619 |
OFD1
|
Health Risk |
Pathogenic |
— |
| RS1131691620 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS1131691622 |
FH
|
Health Risk |
Pathogenic |
— |
| RS1131691623 |
EXT1
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS1131691625 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1131691626 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS1131691627 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1131691628 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS1131691630 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1131691632 |
TUBB3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691635 |
SYNGAP1
|
Health Risk |
Pathogenic |
— |
| RS1131691636 |
AIRE
|
Health Risk |
Likely pathogenic |
— |
| RS1131691637 |
FOLR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral folate transport deficiency, Inborn genetic diseases |
| RS1131691643 |
SPTAN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital cerebellar hypoplasia, Developmental and epileptic encephalopathy |
| RS1131691644 |
GAMT
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1131691645 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1131691646 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1131691647 |
PKP1
|
Health Risk |
Pathogenic |
— |
| RS1131691648 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1131691649 |
AMER1
|
Health Risk |
Pathogenic |
— |
| RS1131691650 |
IQSEC2
|
Health Risk |
Pathogenic |
— |
| RS1131691651 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy |
| RS1131691652 |
IL2RG
|
Health Risk |
Pathogenic |
— |
| RS1131691653 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS1131691654 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS1131691655 |
TTN
|
Health Risk |
Pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS1131691656 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691657 |
IGHMBP2
|
Health Risk |
Pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS1131691658 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS1131691659 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1131691660 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1131691661 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1131691663 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691665 |
LDB3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691666 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS1131691667 |
EYA1
|
Health Risk |
Pathogenic |
Melnick-Fraser syndrome, Branchiootic syndrome 1 |
| RS1131691668 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1131691671 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1131691672 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1131691673 |
DSP
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 8 |
| RS1131691674 |
ENG
|
Health Risk |
Pathogenic |
— |
| RS1131691675 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691676 |
TPP1
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 2, Neuronal ceroid lipofuscinosis |
| RS1131691677 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS1131691678 |
CLCN5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691679 |
BRAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1131691680 |
LAMA3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691681 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS1131691682 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS1131691683 |
PIK3R2
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome, Overgrowth syndrome and/or cerebral malformations |
| RS1131691684 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1131691685 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS1131691686 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1131691687 |
CLCN4
|
Health Risk |
Likely pathogenic |
CLCN4-related disorder, CLCN4-related disorder |
| RS1131691692 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691693 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1131691696 |
TUBB4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 6, Torsion dystonia 4 |
| RS1131691698 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1131691699 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS1131691700 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS1131691702 |
GRIN2B
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1131691703 |
WDR45
|
Health Risk |
Pathogenic |
— |
| RS1131691704 |
H3-3A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691706 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Coffin-Siris syndrome 1 |
| RS1131691708 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1131691709 |
GJB2
|
Health Risk |
Likely pathogenic |
Nonsyndromic genetic hearing loss, Autosomal recessive nonsyndromic hearing loss 1A |
| RS1131691710 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1131691711 |
SETD5
|
Health Risk |
Pathogenic |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1131691712 |
CACNA1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691713 |
MBD5
|
Health Risk |
Pathogenic |
— |
| RS1131691714 |
ZEB2
|
Health Risk |
Pathogenic |
— |